Jeff Duncan Periodic Transaction Report

Filed May 23, 2024 · House Clerk · 2 transactions

U.S. Representative · R · SC-03 · All trades by Jeff Duncan

On May 23, 2024, Rep. Jeff Duncan (R-SC-03) filed a periodic transaction report with the House Clerk disclosing 2 transactions (2 sales) dated Aug 25, 2023.

The filing covers 2 tickers, including $CL, $JD.

Reported amount ranges sum to $2K–$30K. Congress reports trade sizes in ranges, not exact figures.

2 trades were reported more than 45 days after the trade date, outside the STOCK Act's 45-day window. The longest lag in this filing was 272 days.

Source document: House Clerk filing 20000788

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-conviction tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

Jeff Duncan · Sold $JD · Aug 25 · $1K–$15K

0.25LOW

Disclosure speedx 0.250.10

Trade sizex 0.250.20

Cluster activityx 0.150.00

Track recordx 0.35default0.50

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow Jeff Duncan

Get an email the moment Jeff Duncan files the next one. Free, no card, no spam.

Follow free →

Transactions

0 / 2

Buys / sells

Tickers

272d

Longest lag

Tickers in this filing

CL1 JD1

Transactions disclosed

Trade date	Ticker	Asset	Type	Owner	Amount	Lag
Aug 25, 2023	CL	Colgate-Palmolive Company Common Stock (CL)	sell	Self	$1K–$15K	272d
Aug 25, 2023	JD	JD.com, Inc. - American Depositary Shares (JD)	sell	Self	$1K–$15K	272d

← All congressional filings, newest first

From Coldpine Research

Data parsed from the public STOCK Act filing linked above. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. Nothing here is a recommendation. See scores and Coldpine's read on every trade, free with an account →